Skip to content

Study on the obstetrical application value of electromyography of uterus

Study on the obstetrical application value of electromyography of uterus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111653
Enrollment
Unknown
Registered
2025-11-04
Start date
2023-10-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum hemorrhage

Interventions

Between 14 and 24 weeks:None
Between 24 and 34 weeks:None
postpartum:None

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients hospitalized in the obstetrics department for threatened abortion, threatened preterm labor, or full-term labor between August 2023 and July 2024 were selected to undergo uterine electrohysterogram (EHG) after obtaining informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria during Pregnancy: Patients meeting any of the following conditions were excluded from this study: 1. Patients with threatened abortion or threatened preterm labor not caused by uterine contractions (e.g., due to infection, cervical insufficiency, or uterine anomalies). 2. History of adenomyosis. 3. History of uterine fibroids (leiomyoma) with a largest diameter exceeding 3 cm or number exceeding 4. 4. Patients with poor uterine conditions, such as a history of cervical conization. Exclusion Criteria for Postpartum Patients: 1. Patients who underwent postpartum hemorrhage interventions such as uterine packing, uterine artery ligation, or uterine compression sutures. 2. Patients with postpartum hemorrhage due to coagulation disorders, placental factors, or lacerations of the birth canal.

Design outcomes

Primary

MeasureTime frame
Parameters related to uterine electromyography ;

Countries

China

Contacts

Public ContactLv Nan

The Second Affiliated Hospital of Harbin Medical University

13936538221@163.com+86 139 3653 8221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026